Large-scale testing (Phase 3)Ended earlyNCT02569398
What this trial is testing
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
Who this might be right for
Asymptomatic Amyloid-positive
Janssen Research & Development, LLC 557